Severe asthma concomitant with allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.

Published on Apr 14, 2018in Allergology International4.806
· DOI :10.1016/J.ALIT.2018.03.004
Naohiro Oda8
Estimated H-index: 8
(Okayama University),
Nobuaki Miyahara33
Estimated H-index: 33
(RMIT: RMIT University)
+ 7 AuthorsArihiko Kanehiro25
Estimated H-index: 25
(Okayama University)
📖 Papers frequently viewed together
22 Citations
37 Citations
#1Tsuyoshi Oguma (Tokai University)H-Index: 20
#2Masami TaniguchiH-Index: 31
Last. Koichiro Asano (Tokai University)H-Index: 31
view all 13 authors...
Abstract Background Allergic bronchopulmonary aspergillosis (ABPA) is an allergic pulmonary disease characterized by a hypersensitivity reaction to Aspergillus species colonizing the airways. The clinical characteristics of ABPA may differ depending on genetic and environmental background. We performed a nationwide survey to determine the clinical characteristics of ABPA in Japan. Methods In 2013, a questionnaire on physician-diagnosed ABPA/allergic bronchopulmonary mycosis was sent to 903 medic...
30 CitationsSource
#1Yasuhiro Gon (Nihon University)H-Index: 33
#2Shu Hashimoto (Nihon University)H-Index: 40
Abstract Bronchial asthma is characterized by persistent cough, increased sputum, and repeated wheezing. The pathophysiology underlying these symptoms is the hyper-responsiveness of the airway along with chronic airway inflammation. Repeated injury, repair, and regeneration of the airway epithelium following exposure to environmental factors and inflammation results in histological changes and functional abnormalities in the airway mucosal epithelium; such changes are believed to have a signific...
87 CitationsSource
#1Matthew C. Altman (UW: University of Washington)H-Index: 12
#2Jake Lenington (University of Washington Medical Center)H-Index: 1
Last. Andrew G. Ayars (University of Washington Medical Center)H-Index: 1
view all 4 authors...
37 CitationsSource
#1Sergio E. Chiarella (NU: Northwestern University)H-Index: 18
#2Hendrik Sy (Charité)H-Index: 1
Last. Anju T. Peters (NU: Northwestern University)H-Index: 43
view all 3 authors...
Chronic rhinosinusitis (CRS) affects 12.5% of the U.S. population. CRS can be divided into CRS with nasal polyps (CRSwNP) and CRS without nasal polyps. Some individuals with CRSwNP do not respond to standard-of-care medical and surgical management. For these individuals, targeted biologic agents are emerging as an important therapeutic alternative. In this review, we described the most-relevant studies that addressed the use of anti-immunoglobulin E (omalizumab), anti-interleukin 5 (mepolizumab ...
8 CitationsSource
#1Jian-Xiong Li (Tongji University)H-Index: 3
#2Lichao Fan (Tongji University)H-Index: 7
Last. Jin-Fu Xu (Soochow University (Suzhou))H-Index: 21
view all 5 authors...
Abstract Omalizumab, a humanized mAb that binds to IgE, has been an effective therapy for patients with severe allergic asthma; however, there are few clinical trials examining the efficacy of Omalizumab in patients with allergic bronchopulmonary aspergillosis (ABPA) except some case reports. To assess the clinical and immunological effects of Omalizumab in ABPA patients, we made a synthesis review of 102 cases from 30 published literature, analyzed the effects of Omalizumab therapy in ABPA and ...
39 CitationsSource
#1Hector Ortega (GSK: GlaxoSmithKline)H-Index: 33
#2Mark C. Liu (Johns Hopkins University)H-Index: 54
Last. Pascal Chanez (AMU: Aix-Marseille University)H-Index: 86
view all 11 authors...
BackgroundSome patients with severe asthma have frequent exacerbations associated with persistent eosinophilic inflammation despite continuous treatment with high-dose inhaled glucocorticoids with or without oral glucocorticoids. MethodsIn this randomized, double-blind, double-dummy study, we assigned 576 patients with recurrent asthma exacerbations and evidence of eosinophilic inflammation despite high doses of inhaled glucocorticoids to one of three study groups. Patients were assigned to rece...
1,190 CitationsSource
Severe asthma with fungal sensitisation and allergic bronchopulmonary aspergillosis encompass two closely related subgroups of patients with severe allergic asthma. Pulmonary disease is due to pronounced host inflammatory responses to noninvasive subclinical endobronchial infection with filamentous fungi, usually Aspergillus fumigatus. These patients usually do not achieve satisfactory disease control with conventional treatment of severe asthma, i.e. high-dose inhaled corticosteroids and long-a...
54 CitationsSource
#1Philippe Gevaert (UGent: Ghent University)H-Index: 64
#2Nicholas Van Bruaene (UGent: Ghent University)H-Index: 3
Last. Claus Bachert (UGent: Ghent University)H-Index: 119
view all 11 authors...
Background Approximately 85% of nasal polyps (NPs) in white subjects are characterized by prominent eosinophilia. IL-5 is the key driver of eosinophilic differentiation and survival. Objective We sought to investigate the therapeutic potential of inhibiting IL-5 with a humanized mAb as treatment for severe nasal polyposis. Methods Thirty patients with severe nasal polyposis (grade 3 or 4 or recurrent after surgery) refractory to corticosteroid therapy were randomized in a double-blind fashion to...
428 CitationsSource
#1Parameswaran Nair (McMaster University)H-Index: 42
Last. Paul M. O'ByrneH-Index: 120
view all 8 authors...
Background Eosinophilic inflammation, which may be a consequence of interleukin-5 action, is a characteristic feature of some forms of asthma. However, in three previous clinical trials involving patients with asthma, blockade of this cytokine did not result in a significant improvement in outcomes. We studied the prednisone-sparing effect of mepolizumab, a monoclonal antibody against interleukin-5, in a rare subgroup of patients who have sputum eosinophilia and airway symptoms despite continued...
1,109 CitationsSource
#1Roy Patterson (NU: Northwestern University)H-Index: 79
#2Paul A. GreenbergerH-Index: 70
Last. Mary Roberts (NU: Northwestern University)H-Index: 27
view all 4 authors...
: Five stages of allergic bronchopulmonary aspergillosis were identified in 40 patients studied for several years. The stages are acute, remission, exacerbation, corticosteroid-dependent asthma, and fibrotic. The acute stage has all criteria of the disease and responds to prednisone. The remission stage is free from significant asthma or exacerbations. The exacerbation stage has recurrent flares of acute allergic bronchopulmonary aspergillosis. The corticosteroid-dependent asthma stage may have ...
239 CitationsSource
Cited By11
#1Madeline G. Tompkins (Riley Hospital for Children)
#2Rebecca S. Pettit (Riley Hospital for Children)H-Index: 9
OBJECTIVE To review the available literature addressing alternative allergic bronchopulmonary aspergillosis (ABPA) treatment options for patients with cystic fibrosis (CF). DATA SOURCES A literature search of PubMed was performed (January 2002 to April 2021) using the following search terms: allergic bronchopulmonary aspergillosis, aspergillus-related lung disease, cystic fibrosis. Manufacturer prescribing information, clinical practice guidelines, and data from were incorpora...
Abstract We report the case of a 50-year-old man with allergic bronchopulmonary mycosis (ABPM) complicated with bilateral septic arthritis of the knees caused by Methicillin-resistant Staphylococcus aureus (MRSA). He had a background of bronchial asthma and end-stage renal failure on maintenance dialysis. He was treated with 30 mg/day of prednisolone for 14 days for ABPM. He developed bilateral septic arthritis of the knees, caused by MRSA during prednisolone treatment. He underwent bilateral ar...
#2Oranus MohammadiH-Index: 1
Last. Afshin AminiH-Index: 1
view all 4 authors...
Allergic bronchopulmonary aspergillosis (ABPA) is an eosinophilic pulmonary disorder caused by a hypersensitivity reaction to Aspergillus fumigatus that manifests with uncontrolled asthma, peripheral blood eosinophilia, and radiological findings, such as mucus plugging. Early diagnosis and proper treatment of ABPA are essential to prevent irreversible lung damage such as pulmonary fibrosis and bronchiectasis and improve the quality of life of patients. Beside inhaled medication for asthma, anti-...
2 CitationsSource
#1Florence Schleich (University of Liège)H-Index: 21
#2Elleni-Sofia VaiaH-Index: 1
Last. Olivier MichelH-Index: 25
view all 10 authors...
3 CitationsSource
#1Marco CaminatiH-Index: 17
#2Francesco MenzellaH-Index: 16
Last. Gianenrico SennaH-Index: 32
view all 4 authors...
Recent research in the field of bronchial asthma has mainly focused on eosinophilic disease phenotype. Several trials proved the efficacy and safety profile of eosinophils and interleukin (IL)-5 targeting molecules, currently approved for severe asthma and available on the market. They include mepolizumab and reslizumab, IL-5 blocking molecules, and benralizumab, targeting the IL-5 receptor and eliciting a NK cell-mediated antibody-dependent cellular cytotoxicity against eosinophils. Eosinophili...
8 CitationsSource
#1Seiko Soeda (Memorial Hospital of South Bend)H-Index: 7
#2Masako To (Dokkyo Medical University)H-Index: 12
Last. Yasuo To (Memorial Hospital of South Bend)H-Index: 9
view all 8 authors...
11 CitationsSource
#1Seiko Soeda (Memorial Hospital of South Bend)H-Index: 7
#2Yuta Kono (Memorial Hospital of South Bend)H-Index: 9
Last. Yasuo To (Memorial Hospital of South Bend)H-Index: 9
view all 7 authors...
13 CitationsSource
#1Ritesh Agarwal (PGIMER: Post Graduate Institute of Medical Education and Research)H-Index: 61
Last. Ashutosh N. Aggarwal (PGIMER: Post Graduate Institute of Medical Education and Research)H-Index: 58
view all 4 authors...
: Fungal asthma broadly encompasses the presence of fungal sensitization or fungal allergy in patients with asthma. The clinical presentation of fungal asthma can vary from fungal-sensitized asthma at one end to allergic bronchopulmonary mycosis at the other end of the spectrum. Here we present five cases that illustrate some of the most challenging aspects of the diagnosis and management of fungal asthma. The cases are aimed at elucidating complex clinical presentations in fungal asthma such as...
5 CitationsSource
#1Hironobu Tsubouchi (University of Miyazaki)H-Index: 2
#1Hironobu Tsubouchi (University of Miyazaki)H-Index: 9
Last. Masamitsu Nakazato (University of Miyazaki)H-Index: 88
view all 8 authors...
Abstract Allergic bronchopulmonary aspergillosis (ABPA) is a complex hypersensitivity reaction that is associated with an allergic immunological response to Aspergillus species via Th2-related inflammation. The long-term use of a systemic corticosteroid is often needed for the treatment of ABPA. However, systemic corticosteroid treatment imposes a risk of the onset of a nontuberculous mycobacterial infection. Here we report the case of a patient with ABPA who required the long-term use of an ora...
12 CitationsSource
#1Shuko HirotaH-Index: 1
#2Yoichi KobayashiH-Index: 5
Last. Noboru TakayanagiH-Index: 20
view all 7 authors...
Abstract A 56-year-old woman was referred to our hospital for recurrent asthma of 20 years duration. She was diagnosed as having allergic bronchopulmonary aspergillosis on the basis of clinical symptoms, peripheral blood eosinophilia, elevated total serum immunoglobulin E value, positive results of specific IgE and precipitating antibodies against Aspergillus sp., central bronchiectasis, and mucoid impaction. Systemic corticosteroids and anti-fungal therapy improved her symptoms, but the cessati...
14 CitationsSource